Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Intellia Therapeutics Raises USD70 Million in Series B Financing 12
Intellia Therapeutics Raises USD15 Million in Series A Venture Financing 14
Partnerships 15
Intellia Therapeutics and San Raffaele University and Research Hospital Enter into Research Agreement 15
Licensing Agreements 16
CRISPR Therapeutics Enters into Licensing Agreement with Intellia Therapeutics, Caribou Biosciences, ERS Genomics, University of California and University of Vienna 16
Regeneron Pharma Enters into Licensing Agreement with Intellia Therapeutics 18
Novartis Enters into Research and Licensing Agreement with Intellia Therapeutics 20
Intellia Therapeutics Amends Licensing Agreement with Caribou Biosciences 21
Equity Offering 22
Intellia Therapeutics Raises USD150 Million in Public Offering of Shares 22
Intellia Therapeutics Raises USD124.4 Million in IPO 24
Intellia Therapeutics Raises USD70 Million in Private Placement of Series B Preferred Stock 26
Intellia Therapeutics Inc – Key Competitors 28
Intellia Therapeutics Inc – Key Employees 29
Intellia Therapeutics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Aug 01, 2018: Intellia Therapeutics Announces Second Quarter 2018 Financial Results 31
May 01, 2018: Intellia Therapeutics Reports First Quarter 2018 Financial Results 33
Mar 14, 2018: Intellia Therapeutics Announces Fourth Quarter And Full Year 2017 Financial Results 35
Oct 31, 2017: Intellia Therapeutics Announces Third Quarter 2017 Financial Results 37
Aug 01, 2017: Intellia Therapeutics Announces Second Quarter 2017 Financial Results 39
May 02, 2017: Intellia Therapeutics Announces First Quarter 2017 Financial Results 41
Mar 14, 2017: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results 43
Corporate Communications 46
Dec 18, 2017: Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer 46
Jul 24, 2017: Intellia Therapeutics Names Moncef Slaoui, Ph.D. and Frank Verwiel, M.D. to Its Board of Directors and Establishes a Science and Technology Committee 47
Legal and Regulatory 49
Sep 10, 2018: CRISPR Therapeutics, Intellia Therapeutics & Caribou Biosciences provide update on US federal circuit decision upholding the ruling by US patent and trademark Office in Interference Proceeding Relating to CRISPR/Cas9 Genome Editing Technology 49
Apr 13, 2017: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision 50
Product News 51
12/11/2017: Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle Cell Disease at the American Society of Hematology Meeting 51
05/17/2018: Intellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting 52
Mar 08, 2017: Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Intellia Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Intellia Therapeutics Raises USD70 Million in Series B Financing 12
Intellia Therapeutics Raises USD15 Million in Series A Venture Financing 14
Intellia Therapeutics and San Raffaele University and Research Hospital Enter into Research Agreement 15
CRISPR Therapeutics Enters into Licensing Agreement with Intellia Therapeutics, Caribou Biosciences, ERS Genomics, University of California and University of Vienna 16
Regeneron Pharma Enters into Licensing Agreement with Intellia Therapeutics 18
Novartis Enters into Research and Licensing Agreement with Intellia Therapeutics 20
Intellia Therapeutics Amends Licensing Agreement with Caribou Biosciences 21
Intellia Therapeutics Raises USD150 Million in Public Offering of Shares 22
Intellia Therapeutics Raises USD124.4 Million in IPO 24
Intellia Therapeutics Raises USD70 Million in Private Placement of Series B Preferred Stock 26
Intellia Therapeutics Inc, Key Competitors 28
Intellia Therapeutics Inc, Key Employees 29
Intellia Therapeutics Inc, Subsidiaries 30
List of Figures
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Intellia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9